Evaluation of left ventricular hypertrophy in patients requiring permanent pacing

Alexandros Alexopoulos1, Anastasia Perpinia, Nikolaos Michelakakis

  • 1Department of Cardiology, Athens General Hospital, Mesogeion Avenue, 154, 15669 Athens, Greece. aalexop@upatras.gr

Insights

Hypertension is linked to left ventricular hypertrophy, a condition associated with complete atrioventricular block (AVB). This study found a significant association between AVB and abnormal echocardiographic indexes, supporting the hypothesis.

Area of Science:

  • Cardiology
  • Cardiac Electrophysiology

Background:

  • Hypertension can cause left ventricular hypertrophy (LVH), fibrosis, and conduction system degeneration.
  • LVH and conduction abnormalities may necessitate permanent pacemaker implantation.

Purpose of the Study:

  • To investigate the association between left ventricular hypertrophy and specific arrhythmias.
  • To explore the link between LVH and complete atrioventricular block (AVB) and symptomatic sick sinus syndrome (SSS).

Main Methods:

  • Echocardiography was used to assess relative wall thickness (RWT) and left ventricular mass (LVM) in 130 patients with complete AVB, 130 with SSS, and 45 controls.
  • Patients with complete AVB or symptomatic SSS had received permanent pacemakers.

Main Results:

  • A significant association was found between complete AVB and abnormal echocardiographic indexes of left ventricular hypertrophy.
  • The majority of patients diagnosed with complete AVB had a history of hypertension.

Conclusions:

  • The findings support the hypothesis that complete AVB is associated with left ventricular hypertrophy.
  • Hypertension is a likely contributing factor to the development of complete AVB in patients with LVH.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.